REQUEST A DEMO
Total
USD $0.00
Search more companies

Sobhan Oncology Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sobhan Oncology Pharmaceutical Company Public Joint Stock Profile Updated: March 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sobhan Oncology is an Iranian pharmaceutical company producing medicines for anti-cancer treatment. Sobhan Oncology manufacturing plant is located in Rasht Industrial City in north of Iran on an area of 25,000 sq.m. and has production lines for both liquid and solid dosage forms. The company was established in 2002 and became operational in 2010. The company’s first markets were Iran and Syria and after their successful launch, it set foot to Iraq, Yemen, Jordan and Lebanon.

Legal Address
Argentina Sq, Alvand St, No. 5 Aviz Alley
Tehran; Tehran; Postal Code: 1516914611

Contact Details: Purchase the Sobhan Oncology Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.sobhanoncology.com

Basic Information
Total Employees:
Purchase the Sobhan Oncology Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Sobhan Oncology Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Sobhan Oncology Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
2002
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
61%
Purchase this report to view the information.
13%
Purchase this report to view the information.
2%
Subsidiaries
Kbc Company Public Joint Stock
0.02%
Company Performance
Financial values in the chart are available after Sobhan Oncology Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
30.25%
Total operating revenue
30.93%
Operating profit (EBIT)
-10.38%
EBITDA
15.77%
Net Profit (Loss) for the Period
-59.38%
Total assets
41.46%
Total equity
-10.21%
Operating Profit Margin (ROS)
-9.54%
Net Profit Margin
-7.35%
Return on Equity (ROE)
-13.68%
Debt to Equity Ratio
138.63%
Quick Ratio
-0.04%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?